Novel CNS Programs
Treatment-resistant depression, cognitive disorders
Key Facts
Indication
Treatment-resistant depression, cognitive disorders
Phase
Preclinical/Phase I
Status
Active
Company
About Otsuka Holdings
Otsuka Holdings is a multinational healthcare leader founded on the mission 'Otsuka-people creating new products for better health worldwide.' It has achieved global prominence through flagship CNS drugs, a strategic stake in Lundbeck, and blockbuster nutraceutical brands like Pocari Sweat. The company's strategy is built on a diversified four-pillar business model—pharmaceuticals, nutraceuticals, medical devices, and chemicals—driven by a unique culture of creativity ('Souzoususei') and evidence-based validation ('Jisshou').
View full company profile